Squarepoint Ops LLC Infla Rx N.V. Transaction History
Squarepoint Ops LLC
- $93.7 Billion
- Q2 2025
A detailed history of Squarepoint Ops LLC transactions in Infla Rx N.V. stock. As of the latest transaction made, Squarepoint Ops LLC holds 146,034 shares of IFRX stock, worth $121,208. This represents 0.0% of its overall portfolio holdings.
Number of Shares
146,034
Previous 53,513
172.89%
Holding current value
$121,208
Previous $54,000
112.96%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding IFRX
# of Institutions
32Shares Held
17.5MCall Options Held
32.7KPut Options Held
0-
Suvretta Capital Management, LLC New York, NY6.48MShares$5.38 Million0.18% of portfolio
-
683 Capital Management, LLC New York, NY2.48MShares$2.05 Million0.15% of portfolio
-
Ra Capital Management, L.P. Boston, MA1.97MShares$1.64 Million0.03% of portfolio
-
Eversept Partners, LP New York, NY1.64MShares$1.36 Million0.13% of portfolio
-
Woodline Partners LP San Francisco, CA751KShares$623,5510.0% of portfolio
About InflaRx N.V.
- Ticker IFRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,203,800
- Market Cap $36.7M
- Description
- InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...